Jong-Moo Park

Jong-Moo Park

Auto-generated profile, based on publicly available information

Jong-Moo Park

Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
HKHack-Lyoung Kim
Hack-Lyoung Kim
ELEun Mi Lee
Eun Mi Lee
SAShin Young Ahn
Shin Young Ahn
KKKwang-il Kim
Kwang-il Kim
HKHyeon Chang Kim
Hyeon Chang Kim
YKYoung-Kwon Kim
Young-Kwon Kim
Hypertension is the leading cause of death in human being, which shows high prevalence and associated complications that increase the mortality and morbidity. Controlling blood pressure (BP) is very important because it is well known that lowering high BP effectively improves patients’ prognosis. This review aims to provide a focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension. The importance of ambulatory BP and home BP monitoring was further emphasized not only for the diagnosis but also for treatment target. By adopting corresponding BPs, the updated guideline recommended out-of-office BP targets for both standard and intensive treatment. Based on the consensus on corresponding BPs and Systolic Blood Pressure Intervention Trial (SPRINT) revisit, the updated guidelines recommended target BP in high-risk patients below 130/80 mmHg and it applies to hypertensive patients with three or more additional cardiovascular risk factors, one or more risk factors with diabetes, or hypertensive patients with subclinical organ damages, coronary or vascular diseases, heart failure, chronic kidney disease with proteinuria, and cerebral lacunar infarction. Cerebral infarction and chronic kidney disease are also high-risk factors for cardiovascular disease. However, due to lack of evidence, the target BP was generally determined at < 140/90 mmHg in patients with those conditions as well as in the elderly. Updated contents regarding the management of hypertension in special situations are also discussed.

21 November 2013 in International Journal of Stroke
Verified
Journal Article
Closed access
Beomjoon KimBeomjoon Kim
Beomjoon Kim
MHMoon-Ku Han
Moon-Ku Han
TPTai Hwan Park
Tai Hwan Park
SPSang-Soon Park
Sang-Soon Park
KLKyung Bok Lee
Kyung Bok Lee
HBHee-Joon Bae
Hee-Joon Bae

4 February 2022 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
WRWi-Sun Ryu
Wi-Sun Ryu
KHKeun-Sik Hong
Keun-Sik Hong
SJSang-Wuk Jeong
Sang-Wuk Jeong
JPJung E. Park
Jung E. Park
Beomjoon KimBeomjoon Kim
Beomjoon Kim
DKDong-Eog Kim
Dong-Eog Kim
Background: Preclinical data suggest circadian variation in ischemic stroke progression, with more active cell death and infarct growth in rodent models with inactive phase (daytime) than active phase (nighttime) stroke onset. We aimed to examine the association of stroke onset time with presenting severity, early neurological deterioration (END), and long-term functional outcome in human ischemic stroke.Methods and findings: In a Korean nationwide multicenter observational cohort study from May 2011 to July 2020, we assessed circadian effects on initial stroke severity (National Institutes of Health Stroke Scale [NIHSS] score at admission), END, and favorable functional outcome (3-month modified Rankin Scale [mRS] score 0 to 2 versus 3 to 6). We included 17,461 consecutive patients with witnessed ischemic stroke within 6 hours of onset. Stroke onset time was divided into 2 groups (day-onset [06:00 to 18:00] versus night-onset [18:00 to 06:00]) and into 6 groups by 4-hour intervals. We used mixed-effects ordered or logistic regression models while accounting for clustering by hospitals. Mean age was 66.9 (SD 13.4) years, and 6,900 (39.5%) were women. END occurred in 2,219 (12.7%) patients. After adjusting for covariates including age, sex, previous stroke, prestroke mRS score, admission NIHSS score, hypertension, diabetes, hyperlipidemia, smoking, atrial fibrillation, prestroke antiplatelet use, prestroke statin use, revascularization, season of stroke onset, and time from onset to hospital arrival, night-onset stroke was more prone to END (adjusted incidence 14.4% versus 12.8%,p= 0.006) and had a lower likelihood of favorable outcome (adjusted odds ratio, 0.88 [95% CI, 0.79 to 0.98];p= 0.03) compared with day-onset stroke. When stroke onset times were grouped by 4-hour intervals, a monotonic gradient in presenting NIHSS score was noted, rising from a nadir in 06:00 to 10:00 to a peak in 02:00 to 06:00. The 18:00 to 22:00 and 22:00 to 02:00 onset stroke patients were more likely to experience END than the 06:00 to 10:00 onset stroke patients. At 3 months, there was a monotonic gradient in the rate of favorable functional outcome, falling from a peak at 06:00 to 10:00 to a nadir at 22:00 to 02:00. Study limitations include the lack of information on sleep disorders and patient work/activity schedules.Conclusions: Night-onset strokes, compared with day-onset strokes, are associated with higher presenting neurologic severity, more frequent END, and worse 3-month functional outcome. These findings suggest that circadian time of onset is an important additional variable for inclusion in epidemiologic natural history studies and in treatment trials of neuroprotective and reperfusion agents for acute ischemic stroke.

9 August 2007 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
PDF file
HBHee-Joon Bae
Hee-Joon Bae
JLJuneyoung Lee
Juneyoung Lee
JPJong-Moo Park
Jong-Moo Park
OKOhyun Kwon
Ohyun Kwon
JKJa-Seong Koo
Ja-Seong Koo
DPDilip K Pandey
Dilip K Pandey
Background: Little information is available regarding the risk factors for intracranial cerebral atherosclerosis (ICAS), particularly among asymptomatics. Methods: Data from a consecutive series of 1,208 subjects aged ≧40 years, with no history of stroke, and who had undergone transcranial Doppler ultrasonography (TCD) were collected prospectively. The role of classic risk factors was assessed in the presence and severity of asymptomatic ICAS, which was determined by TCD. Results: Regarding the presence of ICAS, the adjusted odds ratios (95% confidence intervals) were as follows: 1.22 (1.08–1.37) for every 10-year increase in age, 1.44 (1.08–1.91) for hypertension and 1.86 (1.33–2.59) for diabetes mellitus. No significant association was observed with regard to male sex, smoking or hyperlipidemia. Conclusion: The findings suggest that age, hypertension and diabetes mellitus are significant risk factors for ICAS in asymptomatic populations.

15 January 2019 in BMC Neurology
Verified
Journal Article
Open access
PDF file
SLSang-Hwa Lee
Sang-Hwa Lee
Beomjoon KimBeomjoon Kim
Beomjoon Kim
MHMoon-Ku Han
Moon-Ku Han
TPTai Hwan Park
Tai Hwan Park
KLKyung Bok Lee
Kyung Bok Lee
HBHee-Joon Bae
Hee-Joon Bae
Futile reperfusion (poor functional status despite successful reperfusion) was observed in up to 67% of patients enrolled in recent endovascular treatment (EVT) clinical trials. We investigated the impact of baseline stroke severity on both futile reperfusion and therapeutic benefit of successful EVT. Using a prospective multicenter stroke registry, we identified consecutive ischemic stroke patients with anterior circulation large artery occlusion, who were reperfused successfully by EVT (Thrombolysis in Cerebral Infarction grade 2b–3). The rate of futile reperfusion was assessed across the initial National Institutes of Health Stroke Scale (NIHSS) scores. The frequency of poor outcomes (modified Rankin scale [mRS] 3–6) according to NIHSS scores was compared between patients revascularized successfully by EVT and those who did not receive EVT, after standardizing for age. Among 21,591 patients with ischemic stroke, 972 (4.5%) received EVT within 12 h of onset, including 440 who met study eligibility criteria. Futile reperfusion was observed in 226 of the 440 study-eligible patients (51.4%) and was associated with stroke severity: 20.9% in NIHSS scores ≤5, 34.6% in 6–10, 58.9% in 11–20, and 63.8% in > 20 (p < 0.001). Nonetheless, the therapeutic benefit of EVT also increased with increasing stroke severity (p for interaction < 0.001): 0.1% in NIHSS ≤5, 18.6% in 6–10, 28.7% in 11–20, and 34.3% in > 20. EVT is more beneficial with increasing stroke severity, although futile reperfusion also increases with higher stroke severity.

1 September 2004 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
DKDong Wook Kim
Dong Wook Kim
JPJong-Moo Park
Jong-Moo Park
BYByung-Woo Yoon
Byung-Woo Yoon
MBMin Jae Baek
Min Jae Baek
JKJung Eun Kim
Jung Eun Kim
SKSangYun Kim
SangYun Kim